Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders.
Omeros stock last closed at $3.15, up 0.64% from the previous day, and has decreased 44.35% in one year. It has underperformed other stocks in the Biotechnology industry by 0.21 percentage points. Omeros stock is currently +242.39% from its 52-week low of $0.92, and -59.61% from its 52-week high of $7.80.
At the moment, there are 57.94M shares of OMER outstanding. The market capitalization of OMER is $182.52M. In the last 24 hours, 172,115 OMER shares were traded.
You need a brokerage account in order to access the NASDAQ market and buy OMER shares.
In our opinion, eToro is the best place to buy stocks. eToro gives you:
Get $10 towards your purchase of stock by creating an account with eToro today.
Open eToro AccountNow that you've selected the right brokerage, you'll need to fill out some personal info so you can buy OMER stock today.
Now that you've filled out your info on one of the most highly reviewed stock market apps, your next step is to transfer the money for your investment:
Watch the video below if you need help transferring money into your new investment account.
Once you have selected the best place to buy Omeros stock, it's crucial to evaluate their stock before you buy, so you actually understand the risk and opportunity.
WallStreetZen was built to help part-time investors do more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on OMER's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge OMER's true value.
You can do additional valuation analysis on OMER's stock here.
You can dive deeper into what analysts are forecasting on the Omeros stock forecast page.
Last year, OMER revenue was $0.00. In the past five year, OMER's revenue has increased by -100% per year. This was slower than the Biotechnology industry average of 28.43%.
You can analyze OMER's earnings and revenue performance here.
Over the past year, executives and large shareholders at OMER have bought more shares than they have sold.
Gregory A. Md Demopulos, Chairman CEO President of OMER, was the latest OMER insider to buy. They bought $25,200.00 worth of OMER stock on Nov 17, 2023.
Dig into more about who owns OMER shares here.
No, Omeros doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
There are two primary order types:
Click the Open button and eToro will execute the order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Now that you own some OMER shares, you'll want to stay up-to-date on your new investment.
Create a watchlist to track the most important metrics related to your OMER stock.
To reiterate, here are the 6 steps to buy Omeros stock:
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to keep track of your new investment in Omeros, create a watchlist today.